Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Berenson

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Seminars in Oncology|January 10, 2003
Advances in the biology and treatment of myeloma bone diseaseJames R Berenson
Current Opinion in Supportive and Palliative Care|August 10, 2011
Antitumor effects of bisphosphonates: from the laboratory to the clinicJames R Berenson
The Oncologist|January 6, 2005
Recommendations for zoledronic acid treatment of patients with bone metastasesJames R Berenson
Nature Reviews. Clinical Oncology|April 25, 2009
Hematology: Bortezomib in newly diagnosed multiple myelomaJames R Berenson
Seminars in Oncology|August 5, 2010
Therapeutic options in the management of myeloma bone diseaseJames R Berenson
Best Practice & Research. Clinical Haematology|July 20, 2005
Myeloma bone diseaseJames R Berenson
Seminars in Oncology|February 14, 2003
Treatment of hypercalcemia of malignancy with bisphosphonatesJames R Berenson
Current Opinion in Supportive and Palliative Care|August 8, 2008
New drugs in multiple myelomaJames R Berenson, Ori Yellin
Clinical Lymphoma & Myeloma|September 1, 2009
Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is importantJames R Berenson, Ori Yellin
Current Opinion in Supportive and Palliative Care|August 9, 2012
Multiple myeloma: improved outcomes with new therapeutic approachesShahrooz Eshaghian, James R Berenson
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Seminars in Oncology|January 10, 2003
Advances in the biology and treatment of myeloma bone diseaseJames R Berenson
Current Opinion in Supportive and Palliative Care|August 10, 2011
Antitumor effects of bisphosphonates: from the laboratory to the clinicJames R Berenson
The Oncologist|January 6, 2005
Recommendations for zoledronic acid treatment of patients with bone metastasesJames R Berenson
Nature Reviews. Clinical Oncology|April 25, 2009
Hematology: Bortezomib in newly diagnosed multiple myelomaJames R Berenson
Seminars in Oncology|August 5, 2010
Therapeutic options in the management of myeloma bone diseaseJames R Berenson
Best Practice & Research. Clinical Haematology|July 20, 2005
Myeloma bone diseaseJames R Berenson
Seminars in Oncology|February 14, 2003
Treatment of hypercalcemia of malignancy with bisphosphonatesJames R Berenson
Current Opinion in Supportive and Palliative Care|August 8, 2008
New drugs in multiple myelomaJames R Berenson, Ori Yellin
Clinical Lymphoma & Myeloma|September 1, 2009
Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is importantJames R Berenson, Ori Yellin
Current Opinion in Supportive and Palliative Care|August 9, 2012
Multiple myeloma: improved outcomes with new therapeutic approachesShahrooz Eshaghian, James R Berenson
Pageof 14